Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-qzcqf Total loading time: 0 Render date: 2025-04-25T12:19:47.327Z Has data issue: false hasContentIssue false

18 - Symptomatic therapies and supportive care issues

Published online by Cambridge University Press:  13 August 2009

By
Alan Valentine  and
Eduardo Bruera
Edited by
Christina A. Meyers  and
James R. Perry
Christina A. Meyers
Affiliation:
University of Texas, M. D. Anderson Cancer Center
James R. Perry
Affiliation:
University of Toronto
Get access

Summary

Introduction

The supportive care of cancer patients routinely involves management of multiple symptoms as well as neuropsychiatric disorders associated with cognitive dysfunction, notably delirium, but also in some instances depression. Cancer therapies themselves (especially medications) can cause or exacerbate cognitive dysfunction. Cognitive disorders of all types are the second most common psychiatric disorders experienced by cancer patients after mood disorders (Derogatis et al., 1983). Patients in particular settings and stages of the disease continuum are at particular risk for cognitive impairment, with potential implications for prognosis. The boundaries between these disorders are not always distinct, which complicates accurate diagnosis and treatment. Co-morbidity is common. The stigma associated with mental illness and the physical burdens of caring for affected patients place family members and other caregivers at increased risk for physical and emotional distress. The common cognitive disorders seen in the oncology setting often respond well to treatment. In other cases, palliation of symptoms is possible and individual patients may respond to creative and unconventional medication interventions. Here we discuss common neuropsychiatric syndromes and clinical settings associated with cognitive dysfunction and altered mental status and behavior, interventions, and potential areas for future research.

Delirium

The American Psychiatric Association defines delirium as a syndrome characterized by rapid onset of impaired cognition, and altered consciousness, and it is presumed to be due to one or more physical or disease-related factors (Table 18.1, American Psychiatric Association, 2000; DSM-IV TR).

Type
Chapter
Information
Cognition and Cancer , pp. 258 - 269
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Ahles, TA, Saykin, AJ (2002). Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 3 [Suppl. 3]: S84–S90.CrossRefGoogle ScholarPubMed
,American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (4th edn. Text Revision edn. Washington, DC: American Psychiatric Association.Google Scholar
Anthony, JC, LeResche, L, Niaz, Uet al. (1982). Limits of the mini-mental state as a screening test for dementia and delirium among hospital patients. Psychol Med 12(2): 397–408.CrossRefGoogle Scholar
Ballon, JS, Feifel, MD (2006). A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 67(4): 554–566.CrossRefGoogle Scholar
Boutros, NN, Struve, F (2002). Electrophysiological assessment of neuropsychiatric disorders. Sem Clin Neuropsychiatry 7(1): 30–41.CrossRefGoogle Scholar
Breitbart, W, Cohen, KR (1998). Delirium. In Holland, JC (ed.) Psycho-oncology (pp. 564–573). New York: Oxford University Press.Google ScholarPubMed
Breitbart, W, Marotta, R, Platt, MMet al. (1996). A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153(2): 231–237.Google Scholar
Breitbart, W, Rosenfeld, B, Roth, Aet al. (1997). The memorial delirium assessment scale. J Pain Symptom Manage 13(3): 128–137.CrossRefGoogle Scholar
Breitbart, W, Gibson, C, Tremblay, A (2002). The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/ caregivers, and their nurses. Psychosomatics 43: 183–194.CrossRefGoogle ScholarPubMed
Brown, TM (2000). Drug-induced delirium. Sem Clin Neuropsychiatry 5(2): 113–124.Google Scholar
Bruera, E, MacMillan, K, Hanson, J, MacDonald, RN (1989). The Edmonton staging system for cancer pain: preliminary report. Pain 37: 203–209.CrossRefGoogle ScholarPubMed
Bruera, E, Miller, MJ, Macmillan, K, Kuehn, N (1992a). Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 48(2): 163–166.CrossRefGoogle Scholar
Bruera, E, Fainsinger, R, MacEachern, T, Hanson, J (1992b). The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. Pain 50(1): 75–77.CrossRefGoogle Scholar
Bruera, E, Miller, L, McCallion, J, Macmillan, K, Krefting, L, Hanson, J (1992c). Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7: 192–195.CrossRefGoogle ScholarPubMed
Bruera, E, Driver, L, Barnes, EAet al. (2003a). Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21(23): 4439–4443.CrossRefGoogle Scholar
Bruera, E, Strasser, F, Shen, Let al. (2003b). The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study. J Pain Symptom Manage 26(5): 1049–1054.CrossRefGoogle Scholar
Bruera, E, Valero, V, Driver, Let al. (2006). Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24(13): 2073–2078.CrossRefGoogle Scholar
Capuron, L, Hauser, P, Hinze-Selch, Det al. (2002). Treatment of cytokine-induced depression. Brain Behav Immunol 16(5): 575–580.CrossRefGoogle Scholar
Caraceni, A, Nanni, O, Maltoni, Met al. (2000). Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 89(5): 1145–1149.3.0.CO;2-X>CrossRefGoogle Scholar
Carter, GL, Dawson, AH, Lopert, R (1996). Drug-induced delirium. Incidence, management and prevention. Drug Safety 15(4): 291–301.CrossRefGoogle Scholar
Cassem, NH, Murray, GB, Lafayette, JM, Stern, TA (2004). Delirious patients. In Stern, T (ed.) Massachusetts General Hospital Handbook of General Hospital Psychiatry (5th edn.). Philadelphia, PA: Mosby.Google Scholar
Crossen, JR, Garwood, D, Glatstein, E, Neuwelt, EA (1994). Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12(3): 627–642.CrossRefGoogle Scholar
Del Fabbro, E, Dalal, S, Bruera, E (2006a). Symptom control in palliative care – Part III: Dyspnea. Dyspnea and delirium. J Palliat Med 9(2): 422–436.CrossRefGoogle Scholar
Del Fabbro, E, Dalal, S, Bruera, E (2006b). Symptom control in palliative care – Part II: Cachexia/anorexia and fatigue. J Palliat Med 9(2): 409–421.CrossRefGoogle Scholar
Derogatis, LR, Morrow, GR, Fetting, J (1983). The prevalence of psychiatric disorders among cancer patients. J Am Med Assoc 249: 751–757.CrossRefGoogle ScholarPubMed
Dobie, DJ (2002). Depression, dementia, and pseudodementia. Semin Clin Neuropsychiatry 7(3): 170–186.CrossRefGoogle Scholar
Fadul, N, Kaur, G, Zhang, T, Palmer, JL, Bruera, E (2007). Evaluation of the Memorial Delirium Assessment Scale (MDAS) for the screening of delirium by means of simulated cases by palliative care health professionals. Support Cancer Care 15(11): 1271–1276.CrossRefGoogle Scholar
Fann, JR, Roth-Roemer, S, Burington, BEet al. (2002). Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer 95(9): 1971–1981.CrossRefGoogle Scholar
Folstein, MF, Folstein, SE, McHugh, PR (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189–198.CrossRefGoogle Scholar
Franco, K, Litaker, D, Locala, J, Bronson, D (2001). The cost of delirium in the surgical patient. Psychosomatics 42(1): 68–73.CrossRefGoogle Scholar
Gagnon, B, Allard, P, Masse, B, DeSerres, M (2000). Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring. J Pain Symptom Manage 19: 412–426.CrossRefGoogle ScholarPubMed
Gagnon, B, Low, G, Schreier, G (2005). Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci 30(2): 100–107.Google Scholar
Gaudreau, JD, Gagnon, P, Roy, MAet al. (2005). Association between psychoactive medications and delirium in hospitalized patients: a critical review. Psychosomatics 46(4): 302–316.CrossRefGoogle Scholar
Homsi, J, Walsh, D, Nelson, KA (2000). Psychostimulants in supportive care. Support Care Cancer 8(5): 385–397.CrossRefGoogle Scholar
Inouye, SK (1998). Delirium in hospitalized older patients: recognition and risk factors. J Geriatric Psychiatry Neurol 11(3): 118–125.CrossRefGoogle Scholar
Inouye, SK (2000). Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies. Ann Med 32(4): 257–263.CrossRefGoogle Scholar
Inouye, SK, Dyck, CH, Alessi, CAet al. (1990). Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Int Med 113(12): 941–948.CrossRefGoogle Scholar
Kelly, KG, Zisselman, M, Cutillo-Schmitter, Tet al. (2001). Severity and course of delirium in medically hospitalized nursing facility residents. Am J Geriatric Psychiatry 9(1): 72–77.CrossRefGoogle Scholar
Lawlor, PG (2002). The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal. Cancer 94(6): 1836–1853.CrossRefGoogle ScholarPubMed
Lawlor, PG, Gagnon, B, Mancini, ILet al. (2000a). Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Int Med 160(6): 786–794.CrossRefGoogle Scholar
Lawlor, PG, Gagnon, B, Mancini, ILet al. (2000b). Delirium as a predictor of survival in older patients with advanced cancer. Arch Int Med 160: 2866–2868.CrossRefGoogle Scholar
Leslie, DL, Zhang, Y, Holford, TRet al. (2005). Premature death associated with delirium at 1-year follow-up. Arch Intern Med 165(14): 1657–1662.CrossRefGoogle Scholar
Lipowski, ZJ (1990). Delirium: Acute Confusional States. New York: Oxford University Press.Google Scholar
Ljubisavljevic, V, Kelly, B (2003). Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 25(5): 345–352.CrossRefGoogle Scholar
Marcantonio, ER, Juarez, G, Goldman, Let al. (1994). The relationship of postoperative delirium with psychoactive medications. J Am Med Assoc 272(19): 1518–1522.CrossRefGoogle Scholar
Massie, MJ, Holland, J, Glass, E (1983). Delirium in terminally ill cancer patients. Am J Psychiatry 140(8): 1048–1050.Google Scholar
Mayo-Smith, MF, Mayo-Smith, MF (1997). Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. J Am Med Assoc 278(2): 144–151.CrossRefGoogle Scholar
Mazzocato, C, Stiefel, F, Buclin, T, Berney, A (2000). Psychopharmacology in supportive care of cancer: a review for the clinician: II Neuroleptics. Support Care Cancer (8)2: 89–97.CrossRefGoogle Scholar
Mercadante, S, Bruera, E (2006). Opioid switching: a systematic and critical review. Cancer Treat Rev 32: 304–315.CrossRefGoogle ScholarPubMed
Meyers, CA, Valentine, AD (1995). Neurological and psychiatric adverse effects of immunological therapy. CNS Drugs 3: 56–68.CrossRefGoogle Scholar
Morita, T, Otani, H, Tsunoda, Jet al. (2000). Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. Support Care Cancer 8(2): 134–137.CrossRefGoogle Scholar
New, P (2001). Radiation injury to the nervous system. Curr Opinion Neurol 14(6): 725–734.CrossRefGoogle Scholar
O'Keeffe, ST, Lavan, JN (1999). Clinical significance of delirium subtypes in older people. Age Ageing 28(2): 115–119.CrossRefGoogle Scholar
Olin, J, Masand, P (1996). Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 37(1): 57–62.CrossRefGoogle Scholar
Pereira, J, Bruera, E (2001). Depression with psychomotor retardation: diagnostic challenges and the use of psychostimulants. J Palliat Med 4(1): 15–21.CrossRefGoogle Scholar
Platt, MM, Breitbart, W, Smith, Met al. (1994). Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 6(1): 66–67.Google Scholar
Prieto, JM, Blanch, J, Atala, Jet al. (2002). Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 20(7): 1907–1917.CrossRefGoogle Scholar
Raison, CL, Demetrashvili, M, Capuron, L, Miller, AH (2005). Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 19(2): 105–123.CrossRefGoogle Scholar
Reifler, BV (2000). A case of mistaken identity: pseudodementia is really predementia. J Am Geriatr Soc 48(5): 593–594.CrossRefGoogle Scholar
Reischies, FM, Neu, P (2000). Comorbidity of mild cognitive disorder and depression – a neuropsychological analysis. Eur Arch Psychiatry Clin Neurosci 250(4): 186–193.CrossRefGoogle Scholar
Ross, CA, Peyser, CE, Shapiro, I, Folstein, MF (1991). Delirium: phenomenologic and etiologic subtypes. Int Psychogeriatr 3(2): 135–147.CrossRefGoogle Scholar
Rozans, M, Dreisbach, A, Lertora, JJ, Kahn, MJ (2002). Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol 20(1): 335–339.CrossRefGoogle Scholar
Sarhill, N, Walsh, D, Nelson, KAet al. (2001). Assessment of delirium in advanced cancer: the use of the bedside confusion scale. Am J Hospice Palliat Care 18: 335–341.CrossRefGoogle ScholarPubMed
Schagen, SB, Muller, MJ, Boogerd, W (2002). Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 9(13): 1387–1397.CrossRefGoogle Scholar
Sood, A, Barton, DL, Loprinzi, CL (2006). Use of methylphenidate in patients with cancer. Am J Hospice Palliat Care 23(1): 35–40.CrossRefGoogle Scholar
Trzepacz, PT (1994). A review of delirium assessment instruments. Gen Hosp Psychiatry 16(6): 397–405.CrossRefGoogle Scholar
Trzepacz, PT (1996). Delirium. Advances in diagnosis, pathophysiology, and treatment. Psychiatrics Clin North Am 19(3): 429–448.CrossRefGoogle Scholar
Trzepacz, PT, Baker, RW, Greenhouse, J (1988). A symptom rating scale for delirium. Psychiat Res 23(1): 89–97.CrossRefGoogle Scholar
Tune, , Damlouji, NF, Holland, Aet al. (1981). Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 2(8248): 651–653.CrossRefGoogle Scholar
Valentine, AD, Bickham, JG (2005). Delirium and substance withdrawal. In Shaw, A (ed.) Acute Care of the Cancer Patient (pp. 545–557). New York: Marcel Dekker.CrossRefGoogle Scholar
Verstappen, CC, Heimans, JJ, Hoekman, K, Postma, TJ (2003). Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63(15): 1549–1563.CrossRefGoogle Scholar
Visser, PJ, Verhey, FR, Ponds, RWet al. (2000). Distinction between preclinical Alzheimer's disease and depression. J Am Geriatr Soc 48(5): 479–484.CrossRefGoogle Scholar
Wefel, JS, Lenzi, R, Theriault, RL, Davis, RN, Meyers, CA (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100(11): 2292–2299.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×